Esposito G, Cazzato M, Rinzivillo M, et al. - The outcomes of patients with type 1 gastric neuroendocrine neoplasia (T1gNENs), receiving treatments with different endoscopic approaches, were analyzed.

• Endoscopic surveillance was performed at regular intervals to manage the patients.

• Forceps or cold snare were used to perform resection in tumors < 10 mm, otherwise mucosal resection (EMR) or submucosal dissection (ESD) were conducted.

• Researchers included 127 T1gNENs identified in 80 patients; 87.4% of these were < 5 mm, whereas 8.7% were 6–10 mm, 3.1% were 11–20 mm, and 0.8% was > 20 mm.

• Outcomes suggest that based on tumor size, the management of T1gNENs may be planned.

• Follow-up using noninterventional endoscopic surveillance could be done in cases with T1gNENs < 5 mm for which the initial removal is not radical.